Health-related quality of life in patients with locally advanced or metastatic breast cancer treated with eribulin mesylate or capecitabine in an open-label randomized phase 3 trial

  1. Cortes, J.
  2. Hudgens, S.
  3. Twelves, C.
  4. Perez, E.A.
  5. Awada, A.
  6. Yelle, L.
  7. McCutcheon, S.
  8. Kaufman, P.A.
  9. Forsythe, A.
  10. Velikova, G.
Revista:
Breast Cancer Research and Treatment

ISSN: 1573-7217,  0167-6806

Any de publicació: 2015

Volum: 154

Número: 3

Pàgines: 509-520

Tipus: Article

DOI: 10.1007/S10549-015-3633-7 GOOGLE SCHOLAR lock_openAccés obert editor
Font de les dades: Scopus